HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA

BACKGROUND: Medulloblastoma (MB) is a highly malignant pediatric brain tumor. Despite aggressive therapy, many patients succumb to the disease, and survivors experience severe side effects from treatment. MBs with high levels of the MYC oncogene have a particularly poor prognosis, and would benefit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wechsler-Reya, Robert J., Pei, Yanxin, Liu, Kun-Wei, Wang, Jun, Esparza, Lourdes A., Maier, Donna L., Li, Xiao-Nan, Cho, Yoon-Jae
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144567/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.22
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi